Sign In
4 Jan 2011 13:19
ο»Ώ
4 January 2011
Β
Ark Therapeutics Group plc
Β
Voting Rights and Capital
Β
Β
In conformity with Section 5.6.1 of the Disclosure and Transparency Rules, Ark Therapeutics Group plc (LSE: AKT) ("Ark" or the "Company") confirms that as at the date of this announcement the Company's issued share capital consists of 209,276,676 ordinary shares of 1 pence each with voting rights. The Company does not hold any shares in treasury.
Β
This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to the interest in, Ark under the FSA's Disclosure and Transparency Rules.
Β
Β
For further information please contact:
Β
Ark Therapeutics Group plc
Dr Edward Bliss, Company Secretary | +44 (0)20 7388 7722 |
Β
Β
Follow the stocks
